AKTAS, A. .; GUNES, O.; OLMEZ BUDAK, F.; DILLER, N.; TUNCER, A. .; AKBULUT, S.; TASKAPAN, M. C.; AYDIN, . C.; KAYAALP, C.; YILMAZ, S. The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure. Annals of Medical Research, [S. l.], v. 29, n. 8, p. 846–852, 2022. Disponível em: http://www.annalsmedres.org/index.php/aomr/article/view/4236. Acesso em: 19 may. 2024.